Skip to content
healthcare.dev

IRBESARTAN

NDC 59746-447, IRBESARTAN, tablet, from Jubilant Cadista Pharmaceuticals Inc..

Product NDC
59746-447
Status
Listed
Labeler
Jubilant Cadista Pharmaceuticals Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203534
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59746-447 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IRBESARTAN75 mg/1

Pharmacologic classes

Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]

Package NDCNDC-11Package
59746-447-0559746044705500 TABLET in 1 BOTTLE (59746-447-05)
59746-447-305974604473030 TABLET in 1 BOTTLE (59746-447-30)
59746-447-905974604479090 TABLET in 1 BOTTLE (59746-447-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/068224c4-a34d-32d7-bb2a-7eed44ccf7d3

Use it

Look up 59746-447 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59746-447 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59746-447. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.